Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03268551 · ClinicalTrials.gov registry record
MEMO-Medical Marijuana and Opioids Study
A clinical trial of Chronic Pain and Opioid Use, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- 257
- Enrollment target
- 2
- Study locations
NCT03268551 is a study of Chronic Pain and Opioid Use that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 257 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (67% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT03268551, a study of Chronic Pain and Opioid Use, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will examine how medical cannabis use affects opioid analgesic use over time, with particular attention to THC/CBD content, HIV outcomes, and severe adverse events.
Conditions Studied
Study Locations (2)
New York
- Montefiore Health System - The Bronx
- Vireo Health - White Plains
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2018-09-04 |
| Est. Completion | 2023-07-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03268551
The ClinicalTrials.gov registry entry for NCT03268551 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (67% lower). The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 0 interventions.
NCT03268551 reports 2 study locations spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03268551 about?
NCT03268551 is a clinical study titled "MEMO-Medical Marijuana and Opioids Study". The study will examine how medical cannabis use affects opioid analgesic use over time, with particular attention to THC/CBD content, HIV outcomes, and severe adverse events.
What is the current status of trial NCT03268551?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2018-09-04. Estimated completion is 2023-07-14.
What conditions does trial NCT03268551 study?
This clinical trial studies the following conditions: Chronic Pain, Opioid Use, HIV/AIDS, Marijuana.
Who is sponsoring clinical trial NCT03268551?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03268551 being conducted?
This trial has 2 study locations across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.